Disclosures. To Cover: To Cover: 3/7/2014. Dan Lowenstein, MD University of California, San Francisco. Research funding:

Size: px
Start display at page:

Download "Disclosures. To Cover: To Cover: 3/7/2014. Dan Lowenstein, MD University of California, San Francisco. Research funding:"

Transcription

1 Disclsures Dan Lwenstein, MD University f Califrnia, San Francisc With special thanks t Samuel F Berkvic, David Gldstein, Erin Heinzen, Heather Medfrd, Ruth Ottman, Ellitt Sherr, Meldie Winawer, EPGP and Epi4K Investigatrs and Persnnel Research funding: NINDS (EPGP, Epi4K, NETT) Epilepsy Study Cnsrtium (unrestricted supprt frm UCB, Lundbeck and the Finding a Cure fr Epilepsy and Seizures Fundatin) T Cver: T Cver: The reality f living with epilepsy Hw imprtant is genetics as a cause f epilepsy? - Genetic epidemilgy A brief verview f epilepsy gene discvery t date The next wave: identifying the genetic causes f mre cmmn, nn-acquired epilepsies The reality f living with epilepsy Hw imprtant is genetics as a cause f epilepsy? - Genetic epidemilgy A brief verview f epilepsy gene discvery t date The next wave: identifying the genetic causes f mre cmmn, nn-acquired epilepsies 1

2 A typical day in clinic 21y man with severe develpmental delay and medically intractable epilepsy since early childhd. Having daily small seizures and mnthly big seizures despite being n 4 AEDs and placement f a vagus nerve stimulatr 16y student s/p left tempral lbectmy 10 years ag, with an apparent fainting spell 6 weeks ag Epilepsy: Impact n the Patient Seizures, typically unpredictable Risk f injury and death C-mrbidities Driving restrictins Underemplyment and unemplyment Lack f independence Stigma, discriminatin and ther scial impacts 2.2M/>65M $9.6B/yr What is the wrst thing abut having epilepsy? T Cver: Fear AED prblems Life limits Stigma The reality f living with epilepsy Hw imprtant is genetics as a cause f epilepsy? - Genetic epidemilgy Lss f cnfidence Family cncerns Medical care prblems Physical prblems Percent f Respndents (n=1023) A brief verview f epilepsy gene discvery t date The next wave: identifying the genetic causes f mre cmmn, nn-acquired epilepsies Fisher. Epilepsy and Behavir 1:S9-S14,

3 Traditinal View f Epilepsy Causatin Genetic Epidemilgy Others Strke Trauma Cngenital Unknwn Idipathic Rchester Study Hauser et al 1975 Res Nerv Ment Dis 26:11, 1947 Vadlamudi et al. Neurlgy 62:1127, 2004 Res Nerv Ment Dis 26:11,

4 Genetic Epidemilgy Twin Studies Case-wise cncrdance Syndrme Mnzygus Dizygus Generalised (n = 99) p = Fcal (n = 103) p = Febrile (n = 180) p = Unclassified (n = 36) p = 0.1 The risks f seizure disrders amng relatives f patients with childhd nset epilepsy J.F. Annegers, Ph.D., W.A. Hauser, M.D., V.E. Andersn, Ph.D., and L.T. Kurland, M.D. NEUROLOGY 1982;32:174-9 Chrt study f descendants f parents f prbands with epilepsy 196 cases f idipathic epilepsy with seizure nset between 0 and 15 years, and 60 cases f islated idipathic seizures frm Rchester, MN frm 1935 and 1974 Berkvic et al Ann Neurl 1998 Vadlamudi and Berkvic 2012 Risks f epilepsy in prbands with epilepsy Relatinship Observed Cases Expected Cases Relative Risk 95% Cnfidence Interval Sibs Children Nieces/nephews Grandchildren Half-sibs Grandnieces/nephews Greatgrandnieces/nephews Annegers et al. Neurlgy 32:174,

5 6 3/7/2014 T Cver: Rare Gene Mutatins The reality f living with epilepsy Hw imprtant is genetics as a cause f epilepsy? - Genetic epidemilgy A brief verview f epilepsy gene discvery t date The next wave: identifying the genetic causes f mre cmmn, nn-acquired epilepsies Nature Genetics 11:201, 1995 VI V IV III II I II III IV V VI Epilepsy Genes: 2014 GENE ARX ATP1A2 CACNA1A CACNAB4 CDKL5 (STK9) CHRNA4 CHRNAB2 CHRNA7 CLCN2 EFHC1 GABRD GABRA1 GABRG2 KCNQ2 KCNQ3 KCNMA1 KCNT1 KCTD7 LGI1 PCDH19 PLCB1 PRRT2 SCN1A SCN1B SCN2A SCN8A SLC2A1 STXBP1 TBC1D24 ASSOCIATED EPILEPSY SYNDROME(S) Infantile spasms Benign familial infantile cnvulsins Familial hemiplegic migraine and epilepsy Absence epilepsy and episdic ataxia Infantile spasms Autsmal dminant ncturnal frntal lbe epilepsy Autsmal dminant ncturnal frntal lbe epilepsy Childhd absence epilepsy Juvenile absence epilepsy Childhd absence epilepsy Benign familial nenatal cnvulsins Ohtahara Syndrme Benign familial nenatal cnvulsins Generalized epilepsy with parxysmal dyskinesia Malignant migrating partial seizures f infancy Severe autsmal dminant ncturnal frntal lbe epilepsy Prgressive myclnic epilepsy Autsmal dminant partial epilepsy with auditry features Epilepsy in females with mental retardatin Migrating partial epilepsy f infancy Benign familial infantile seizures Severe myclnic epilepsy f infancy (Dravet syndrme) Migrating partial epilepsy f infancy Benign familial nenatal/infantile cnvulsins Infantile epileptic encephalpathy + SUDEP Early-nset absence epilepsy Epilepsy with parxysmal exercise-induced dyskinesia Partial nset epilepsy with intellectual disability Familial infantile myclnic epilepsy Fcal epilepsy with develpmental disability Epilepsy Genes: 2014 GENE ARX ATP1A2 CACNA1A CACNAB4 CDKL5 (STK9) CHRNA4 CHRNAB2 CHRNA7 CLCN2 EFHC1 GABRD GABRA1 GABRG2 KCNQ2 KCNQ3 KCNMA1 KCNT1 KCTD7 LGI1 PCDH19 PLCB1 PRRT2 SCN1A SCN1B SCN2A SCN8A SLC2A1 STXBP1 TBC1D24 ASSOCIATED EPILEPSY SYNDROME(S) Infantile spasms Benign familial infantile cnvulsins Familial hemiplegic migraine and epilepsy Absence epilepsy and episdic ataxia Infantile spasms Autsmal dminant ncturnal frntal lbe epilepsy Autsmal dminant ncturnal frntal lbe epilepsy Childhd absence epilepsy Juvenile absence epilepsy Childhd absence epilepsy Benign familial nenatal cnvulsins Ohtahara Syndrme Benign familial nenatal cnvulsins Generalized epilepsy with parxysmal dyskinesia Malignant migrating partial seizures f infancy Severe autsmal dminant ncturnal frntal lbe epilepsy Prgressive myclnic epilepsy Autsmal dminant partial epilepsy with auditry features Epilepsy in females with mental retardatin Migrating partial epilepsy f infancy Benign familial infantile seizures Severe myclnic epilepsy f infancy (Dravet syndrme) Migrating partial epilepsy f infancy Benign familial nenatal/infantile cnvulsins Infantile epileptic encephalpathy + SUDEP Early-nset absence epilepsy Epilepsy with parxysmal exercise-induced dyskinesia Partial nset epilepsy with intellectual disability Familial infantile myclnic epilepsy Fcal epilepsy with develpmental disability 5

6 Epilepsy Genes: 2014 GENE ARX ATP1A2 CACNA1A CACNAB4 CDKL5 (STK9) CHRNA4 CHRNAB2 CHRNA7 CLCN2 EFHC1 GABRD GABRA1 GABRG2 KCNQ2 KCNQ3 KCNMA1 KCNT1 KCTD7 LGI1 PCDH19 PLCB1 PRRT2 SCN1A SCN1B SCN2A SCN8A SLC2A1 STXBP1 TBC1D24 ASSOCIATED EPILEPSY SYNDROME(S) Infantile spasms Benign familial infantile cnvulsins Familial hemiplegic migraine and epilepsy Absence epilepsy and episdic ataxia Infantile spasms Autsmal dminant ncturnal frntal lbe epilepsy Autsmal dminant ncturnal frntal lbe epilepsy Childhd absence epilepsy Juvenile absence epilepsy Childhd absence epilepsy Benign familial nenatal cnvulsins Ohtahara Syndrme Benign familial nenatal cnvulsins Generalized epilepsy with parxysmal dyskinesia Malignant migrating partial seizures f infancy Severe autsmal dminant ncturnal frntal lbe epilepsy Prgressive myclnic epilepsy Autsmal dminant partial epilepsy with auditry features Epilepsy in females with mental retardatin Migrating partial epilepsy f infancy Benign familial infantile seizures Severe myclnic epilepsy f infancy (Dravet syndrme) Migrating partial epilepsy f infancy Benign familial nenatal/infantile cnvulsins Infantile epileptic encephalpathy + SUDEP Early-nset absence epilepsy Epilepsy with parxysmal exercise-induced dyskinesia Partial nset epilepsy with intellectual disability Familial infantile myclnic epilepsy Fcal epilepsy with develpmental disability Helbig and Lwenstein, Current Opin Neurl. 2013; 26: The neurbilgical spectrum f the epilepsies epilepsies with plygenic inheritance Others Strke Trauma Cngenital Unknwn Idipathic Genetic/ Epigenetic The reality f living with epilepsy Hw imprtant is genetics as a cause f epilepsy? - Genetic epidemilgy T Cver: single gene epilepsies Genetic epilepsies with a majr acquired cause trauma, infectins, vascular etc. Structural/Metab lic Mdified frm Helbig et al 2008 A brief verview f epilepsy gene discvery t date The next wave: identifying the genetic causes f mre cmmn, nn-acquired epilepsies 6

7 An internatinal, multi-center, cllabrative research effrt funded by the Natinal Institute f Neurlgical Disrders and Strke designed t advance ur understanding f the genetic basis f epilepsy Ruben Kuzniecki, MD The genesis f the prject: First-hand awareness f the tremendus impact that epilepsy has n individuals and sciety, and the current limitatins f what we ffer ur patients Recgnitin f accelerating advances in mlecular analyses, and the pivtal rle f phenmics Indisputable need fr a natinal effrt t achieve success Lng-term impact f creating a natinal resurce Enthusiasm fr wrking with extremely mtivated, talented, and willing cllabratrs Overview f Study and Prtcl Overall Objective: T create a database cntaining in-depth phentype and gentype data frm a large number f patients with epilepsy frm thrughut the United States, and t investigate the genetic influences n cmmn and rare frms f epilepsy and pharmacresistance. 7

8 IGE Prband (n=750) LRE Prband (n=750) IS Prband (n=250) LGS Prband (n=250) IGE Sibling (n=750) LRE Sibling (n=750) (r parent/child pairs) Parents (n=500) Parents (n=500) Flw f Data fr IGE/LRE Sib Pairs Cnfirm Eligibility fr Prband and Permissin t Cntact Sibling Pre-screen Cnsent Screening Interview Review f Medical Recrd, EEG, MRI Bld Draw and Shipment t Criell: Prband Identify Ptential Prband: Patient with IGE r LRE with a Full-Sibling with Nnacquired Epilepsy Cnfirm Eligibility fr Sibling: Pre-screen Cnsent Screening Interview Review f Medical Recrd, EEG, MRI Bld Draw and Shipment t Criell: Sibling Phentyping f Prband and Sibling: Diagnstic Interview Medical Recrd Abstractin Supplemental Frms AED Data Sheet MCD Prband (n=250) Parents (n=500) EEG Cre Review EEG Review by Site MRI Cre Review Phentyping Cre Review 3,750 1,500 Final Cnsensus f Diagnsis Phentyping Cmplete Study-Wide Enrllment as f 2/22/2014 Ttal Enrllment Target # Cnsented # Eligible Familial Aggregatin f Seizure Semilgy in the Epilepsy Phenme/Genme Prject Meldie Winawer, Rbyn Fahlstrm, Cahtherine Shain, Daniel Rabinwitz and the EPGP Investigatrs Study f 1055 participants, including 412 with nn-acquired fcal epilepsy and 643 with generalized epilepsy. Familial aggregatin was assessed by lgistic regressin analysis f relatives traits (dependent variable) by prbands traits (independent variable), estimating the dds rati fr each symptm in a relative given presence versus absence f the symptm in the prband End f Mnth 33,816 activities 6,960,307 data pints Seizure type Simple fcal Cmplex fcal Secndarily generalized tnic-clnic Fcal Epilepsy Ictal Symptms Mtr Autnmic Psychic Aphasic Generalized Epilepsy generalized tnic-clnic absence myclnic atypical absence atnic reflex generalized 8

9 Phentyping & Clinical Infrmatics Cre Phentype Data Steering Cmmittee Epi4K PIs & NINDS Administrative Cre Data Sharing Publicatins Epi4K Charter Regulatry ELSI Prject 1: Epileptic Encephalpathies Prject 2: Multiplex Families & Pairs Prject 3: Prgnsis Prject 4: CNV Detectin Sequencing Data Sequencing, Bistatistics & Biinfrmatics Cre Epi4K Prject 1- Epileptic Encephalpathies (EE) Infantile Spasms (IS) 1 in 3000 live births and nset between 4-12 mnths f life Characteristic chatic interictal & EEG pattern f hypsarrhythmia, the sine qua nn f the syndrme 50-60% f IS cases have develpmental brain malfrmatins, tuberus sclersis cmplex, chrmsmal syndrmes and metablic cnditins Patients may evlve int LGS Lennx-Gastaut syndrme (LGS) Onset between 1-8 years Characterized by mixed seizure types and intellectual disabilities Cause unknwn in abut 25-35% cases, symptmatic f structural r metablic abnrmalities EPGP: Epileptic Encephalpathies Mst EE d nt shw trans-generatinal transmissin Mst families d nt have sibling recurrence Hypthesis: many IS/LGS patients have de nv causative mutatins Target families t highlight increased chance: Bth bilgical parents available N epilepsy in parents N familial recurrence Target genes that functin at the cre f EE Exclude patients with knwn causes Exclude patients with severe Develpmental Delay prir t seizure nset Nature 501: ,

10 Distributin f de nv mutatins Number f EE prbands Number f de nv mutatins per EE prband Slavé Petrvski Epi4K and EPGP Investigatrs. Nature 501: , 2013 Degree t which genes have mre, r less, cmmn functinal variatin than expected given the amunt f presumably neutral variatin they carry Distributin f de nv mutatins in intlerant genes Sum f all cmmn (>0.1%MAF) functinal variants in gene TOLERANT (extreme 2% f genme) INTOLERANT (extreme 2% f genme) HLA Olfactry receptrs Calcium channels % f de nv mutatins In intlerant genes Sum f all variant sites in gene Epi4K and EPGP Investigatrs. Nature 501: ,

11 Genes with greater than ne de nv SNV in 27 tris, and the prbabilities f getting greater than r equal bserved de nv mutatin tally by chance Gene Chr Average effectively captured length (bp) Weighted mutatin rate De nv mutatin number P-value SCN1A x x10-9 STXBP x x10-11 GABRB x x10-10 CDKL5 X x x10-7 ALG13 X x x10-12 DNM x x10-4 HDAC x x10-4 SCN2A x x10-9 SCN8A x x10-4 Epi4K and EPGP Investigatrs. Nature 501: , likely de nv mutatins in intlerant genes that are already disease-causing: CACNA1A CHD2 FLNA GRIN1 GABRA1 GRIN2B HNRNPU IQSEC2 KCNQ2 KCNT1 MTOR NEDD4L Episdic ataxia, familial hemiplegic migraine, ASD ASD and ID with seizures Periventricular hetertpia ID ASD Variety f neurdevelpmental phentypes ID with seizures ID; ne patient with infantile spasms ID with seizures ADNFLE and epilepsy f infancy with migrating fcal seizures Hemimegalencephaly Phtsensitive epilepsy and indirectly t infantile epilepsy The de nv mutatins are drawn preferentially frm particular gene sets: In channels (p=1.3x10-3 )* Mngenic disrders with epilepsy (p=1.5x10-2 ) ASD (p=9.4x10-2 ) ID (p=7.8x10-3 ) FMRP-regulated genes (p=4.2x10-4 ) *- after excluding genes knwn t cause EE Ingenuity Pathway Analysis EE: p=0.001 ASD/ID: p=0.001 FMRP: p=1.2x10-9 Clinical implicatins Significant genetic hetergeneity underlying IS and LGS These are the first mutatins identified t be likely causative in LGS 3 mutatins fund in genes (MTOR, DCX, FNLA) assciated with brain malfrmatins but nrmal MRIs in all 3 patients 2 genes (SCN8A and GABRB3) each with de nv mutatins in ne pt. with IS and ne pt. with LGS, despite n hx f IS in the LGS pt. 5 pts. with LGS with de nv mutatins in SCN1A; in all 5 cases a re-review suggests these individuals had a clinical curse cnsistent with Dravet syndrme despite an initial diagnsis f LGS 11

12 n=143 MD r DO 73 PhD 24 RN 7 PharmD 3 MPH 11 Masters (ther) persn-years f graduate-level training! Bichemical Genetics Bistatistics Chemistry Clinical Infrmatics Clinical Neurphysilgy Clinical Research Electrical Engineering Epidemilgy Epilepsy Genetic Cunseling Genetics Mental Health Cunseling Micrbilgy Mlecular Bilgy Mlecular Genetics Neurgenetics Neurlgy Neurpathlgy Neurphysilgy Neurscience Neurscience Pediatric Neurlgy Pharmaceutical Sciences Pharmaclgy Psychmetrics Scial Psychlgy Scial Psychlgy Cnclusins Strke Others Trauma Cngen ital Genetic The degree f suffering assciated with epilepsy is hrrible. We appear t again be n the upswing in deciphering the genetic architecture f the epilepsies. Large-scale, cllabrative effrts are essential t future prgress. Thank yu! The results are already having an imprtant impact n clinical care. The latest EPGP/Epi4K results suggest that even thugh patients may carry very rare r private mutatins cnferring risk, many f the genes affected by these mutatins can be rganized int functinally-related grups. This may prvide insight int the develpment f new therapies and individual treatment respnses. 12

Epi4K. Epi4K Consortium. Epi4K: gene discovery in 4,000 genomes, Epilepsia, 2012 Aug;53(8):

Epi4K. Epi4K Consortium. Epi4K: gene discovery in 4,000 genomes, Epilepsia, 2012 Aug;53(8): Epi4K Epi4K Consortium. Epi4K: gene discovery in 4,000 genomes, Epilepsia, 2012 Aug;53(8):1457-67. Genetics of Epileptic Encephalopathies Infantile Spasms (IS) 1 in 3000 live births and onset between 4-12

More information

Pondering Epilepsy Classification (actually a few thoughts on the impact of genetic analyses of the epilepsies) Genetics of Epilepsies

Pondering Epilepsy Classification (actually a few thoughts on the impact of genetic analyses of the epilepsies) Genetics of Epilepsies Pondering Epilepsy Classification (actually a few thoughts on the impact of genetic analyses of the epilepsies) Dan Lowenstein UCSF Department of Neurology and the UCSF Epilepsy Center To Cover: 1. Update

More information

What Can We Learn About Epilepsy from Genome Sequences

What Can We Learn About Epilepsy from Genome Sequences What Can We Learn About Epilepsy from Genome Sequences David Goldstein, Ph.D. Professor & Director Center for Human Genome Variation Duke University American Epilepsy Society Annual Meeting Disclosure

More information

ERN EpiCARE. A European Reference Network for Rare and Complex Epilepsies. Petr Marusic Motol University Hospital, Prague

ERN EpiCARE. A European Reference Network for Rare and Complex Epilepsies. Petr Marusic Motol University Hospital, Prague ERN EpiCARE A European Reference Network for Rare and Complex Epilepsies Petr Marusic Motol University Hospital, Prague Disclosure I have no actual or potential conflict of interest in relation to this

More information

EPILEPSY. An overview of issues important in documentation

EPILEPSY. An overview of issues important in documentation EPILEPSY An verview f issues imprtant in dcumentatin Cmpiled by: Launa Fackrell - Clinical Dcumentatin Imprvement Manager Letitia Sammns, MBA, RHIT Clinical Dcumentatin Imprvement Specialist Crystal Pwell,

More information

A European Reference Network for rare and complex epilepsies. J Helen Cross Coordinator

A European Reference Network for rare and complex epilepsies. J Helen Cross Coordinator A European Reference Network for rare and complex epilepsies J Helen Cross Coordinator The epilepsies a group of rare diseases Early myoclonic encephalopathy PIGA, SETBP1, SIK1, SLC25A22 Dravet syndrome

More information

Overview. Individuals with Foxp1-related disorder A mouse model for Foxp1-related disorder syndrome Stem cells in Foxp1-related disorder

Overview. Individuals with Foxp1-related disorder A mouse model for Foxp1-related disorder syndrome Stem cells in Foxp1-related disorder Fxp1 Syndrme Jseph D Buxbaum, PhD Directr, Seaver Autism Center Deputy Chair, Department f Psychiatry Icahn Schl f Medicine at Munt Sinai www.seaverautismcenter.rg Overview Individuals with Fxp1-related

More information

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Dr. Sarah Weckhuysen, MD, PhD Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Common Prevalence 4-8/1000 Life time incidence 3% Key symptom = seizures Nature Reviews

More information

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Dr. Sarah Weckhuysen, MD, PhD Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Sarah Weckhuysen No relevant financial relationships with any commercial interests.

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening

More information

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit. Cmprehensive Diagnstic Evaluatin (CDE) Guidelines t Access the Applied Behavir Analysis (ABA) Benefit May 5, 2017 Clinical infrmatin that utlines medical necessity is required t supprt the need fr initial

More information

APA-accredited: YES NO X. Brown University. Stephen Salloway, M.D. (Primary Supervisor) Paul Malloy, Ph.D.

APA-accredited: YES NO X. Brown University. Stephen Salloway, M.D. (Primary Supervisor) Paul Malloy, Ph.D. Clinical Psychlgy Training Prgrams at Brwn: A Cnsrtium f the Prvidence VA Medical Center, Lifespan, and Care New England Pstdctral Fellwship Training Prgram Pstdctral Fellwship Descriptin: RESEARCH FOCUS

More information

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.

More information

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels Targeted s and Methodology Details for Epilepsy/Seizure tic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Epilepsy/Seizure tic Panels Epilepsy Expanded Panel Epilepsy Expanded

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

Intraventricular Hemorrhage in the Neonate. NICU Night Team Curriculum

Intraventricular Hemorrhage in the Neonate. NICU Night Team Curriculum Intraventricular Hemrrhage in the Nenate NICU Night Team Curriculum Objectives T describe the epidemilgy and risk factrs f IVH T understand the anatmy and pathphysilgy invlved in IVH T demnstrate the grading

More information

Influenza (Flu) Fact Sheet

Influenza (Flu) Fact Sheet Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_epilepsy 1/28/14 10/2017 10/2018 10/2017 Description of Procedure or Service Description

More information

Ill Health. Unit reference number: L/616/7295 Level: 3. Credit value: 3 Guided learning hours: 16. Unit summary

Ill Health. Unit reference number: L/616/7295 Level: 3. Credit value: 3 Guided learning hours: 16. Unit summary Unit 11: Understand Mental Ill Health Unit reference number: L/616/7295 Level: 3 Unit type: Optinal Credit value: 3 Guided learning hurs: 16 Unit summary Mental ill health culd be ne f the mst serius health

More information

EPILEPSY IN INFANCY. AK Gururaj, R Pratap Chand, K E Choo SING MED J. 1988; 29: ABSTRACT

EPILEPSY IN INFANCY. AK Gururaj, R Pratap Chand, K E Choo SING MED J. 1988; 29: ABSTRACT EPILEPSY IN INFANCY AK Gururaj, R Pratap Chand, K E Ch ABSTRACT The clinical and electrencephalgraphic (EEG) filatures f epilepsy in the first year f life were studied in 5 infants admitted with a histry

More information

Top 10 Causes of Disability

Top 10 Causes of Disability Tp 10 Causes f Disability Disability can happen t anyne, f any age. Thugh sme may be the result f accidents r injuries that are unavidable, many disabilities are the result f diseases and health cnditins

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

W81XWH TITLE: PRINCIPAL INVESTIGATOR: Charles Bernick, MD, MPH

W81XWH TITLE: PRINCIPAL INVESTIGATOR: Charles Bernick, MD, MPH AWARD NUMBER: 1310486 XXXXXX W81XWH-13-1-0486 TITLE: Recgnitin f Chrnic Traumatic Encephalpathy thrugh FDDNP PET Imaging PRINCIPAL INVESTIGATOR: Charles Bernick, MD, MPH CONTRACTING ORGANIZATION: Cleveland

More information

Awareness of Autistic Spectrum Conditions

Awareness of Autistic Spectrum Conditions Unit 21: Awareness f Autistic Spectrum Cnditins Unit reference number: H/616/7304 Level: 2 Unit type: Optinal Credit value: 2 Guided learning hurs: 17 Unit summary This unit intrduces yu t autistic spectrum

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is

More information

Lyme Disease Surveillance in North Carolina

Lyme Disease Surveillance in North Carolina Lyme Disease Surveillance in Nrth Carlina 2008-2014 Carl Williams DVM Megan Sanza MPH Cmmunicable Disease Branch Divisin f Nrth Carlina Public Health Lyme Disease Surveillance in Nrth Carlina 2008-2014

More information

Introduction to Psychological Disorders (Myers for AP 2 nd Edition, Module 65)

Introduction to Psychological Disorders (Myers for AP 2 nd Edition, Module 65) Intrductin t Psychlgical Disrders (Myers fr AP 2 nd Editin, Mdule 65) Why are we s interested in learning abut psychlgical disrders? The Wrld Health Organizatin reprts that peple suffer frm mental r behavir

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

FTD RESEARCH: The Value of Studies and Opportunities for Involvement

FTD RESEARCH: The Value of Studies and Opportunities for Involvement FTD RESEARCH: The Value f Studies and Opprtunities fr Invlvement Sarah Lawrence, MS Research Prgram Manager Ann Fishman, MBA Sr. Research Crdinatr Weiyi Mu, ScM Genetic Cunselr Suzanne Dana Spuse/Caregiver

More information

FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES

FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES Appendix h STUDY NUMBER: COST OF UNSAFE ABORTION FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES T be administered abut 2-3 weeks after leaving the health facility 1. IDENTIFICATION 101. Patient identificatin

More information

Chapter 5 Anxiety Disorders

Chapter 5 Anxiety Disorders Test Review 2 Chapter 5 Anxiety Disrders Mst cmmn and effective frm f treatment = Expsure Anxiety Disrders Mst cmmn psychiatric disrders Phbias mst cmmn f the anxiety disrders Often Cmrbid with Majr Depressin

More information

Medication Assisted Treatment for Opioid Use Disorder in Rural Colorado

Medication Assisted Treatment for Opioid Use Disorder in Rural Colorado Medicatin Assisted Treatment fr Opiid Use Disrder in Rural Clrad Why is piid use disrder getting s much attentin? Opiid Use Disrder (OUD) has seen an epidemic rise in the United States ver the past decade.

More information

DEMENTIA. DESCRIPTION: a progressive, degenerative disease of the brain, which causes impairment of thinking and memory

DEMENTIA. DESCRIPTION: a progressive, degenerative disease of the brain, which causes impairment of thinking and memory DEMENTIA Dementia a syndrme cnsisting f a number f symptms including lss f memry, judgment and reasning, and changes in md and behavir the changes may affect a persn's ability t functin at wrk, in scial

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

Strategic Plan Publication No: EO-SP

Strategic Plan Publication No: EO-SP Strategic Plan 2017-2019 Publicatin N: EO-SP-170223 +61 2 9036 5002 www.pcg.rg.au pcg.ffice@sydney.edu.au This dcument was prepared by the PCG Executive Office PCG Publicatin number: EO-SP-170223 Psych-nclgy

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

Risk factors in health and disease

Risk factors in health and disease Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk

More information

Newborn Hearing Screening, Early Identification and Loss to Follow-Up

Newborn Hearing Screening, Early Identification and Loss to Follow-Up Newbrn Hearing Screening, Early Identificatin and Lss t Fllw-Up Prgram in Audilgy and Cmmunicatin Sciences Pediatric Audilgy Specializatin The cntents f this presentatin were develped under a grant frm

More information

2012 Indiana Parent/Family Needs Assessment Survey

2012 Indiana Parent/Family Needs Assessment Survey Reprt t the Legislative Cmmissin n Autism: 2012 2012 Indiana Parent/Family Needs Assessment Survey Cnducted By: Cathy Pratt, Ph.D., BCBA-D Directr Sctt Bellini, Ph.D. Prfessr, Schl f Educatin Indiana Resurce

More information

W2D- Workshop #4 Cases I learned From Ann Hyslop, MD

W2D- Workshop #4 Cases I learned From Ann Hyslop, MD W2D- Wrkshp #4 Cases I learned Frm Ann Hyslp, MD Pediatric Neurlgy and Epilepsy Miami Children s Hspital Miami, Flrida Disclsure f Relevant Relatinship Dr. Hyslp (r spuse/partner) has nt had (in the past

More information

Nonclinical factors associated with premature termination of adjuvant chemotherapy for stage I-III breast cancer

Nonclinical factors associated with premature termination of adjuvant chemotherapy for stage I-III breast cancer Nnclinical factrs assciated with premature terminatin f adjuvant chemtherapy fr stage I-III breast cancer Xia-Cheng Wu, Trevr Thmpsn, Meichin Hsieh, Meijia Zhu, Patricia Andrews, Michelle Lch, Timthy Styles,

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe

More information

Table e-1: Investigation of 33 patients with early onset epilepsy for KCNT1 mutations.

Table e-1: Investigation of 33 patients with early onset epilepsy for KCNT1 mutations. Table e1: Investigation of 33 patients with early onset epilepsy for KCNT1 mutations. Patient Phenotype Screening Method Diagnostic Karyotype Sanger sequencing NGS Diagnostic Panel WES chromosomal microarray

More information

ALCAT FREQUENTLY ASKED QUESTIONS

ALCAT FREQUENTLY ASKED QUESTIONS 1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age

More information

iprex Fact Sheet: Key Results

iprex Fact Sheet: Key Results EMBARGOED UNTIL RELEASE Tuesday, 23 Nvember 2010, 8 a.m. EST CONTACT Mark Aurigemma; 646-270-9451; mark@aucmm.net Pedr Gicchea; 415-490-8350 pgicchea@gladstne.ucsf.edu iprex Fact Sheet: Key Results iprex

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated

More information

Relationship between physicians self-efficacy assessment and ratings of supervisory physicians performance (work in progress)

Relationship between physicians self-efficacy assessment and ratings of supervisory physicians performance (work in progress) Relatinship between physicians self-efficacy assessment and ratings f supervisry physicians perfrmance (wrk in prgress) Phil Byrne, Ed.D. Children s Mercy Hspital Michael V. Williams, Ph.D. Wales Behaviral

More information

Managing the Symptoms of Stroke

Managing the Symptoms of Stroke Unit 26: Recgnising and Managing the Symptms f Strke Unit reference number: F/616/7312 Level: 2 Unit type: Optinal Credit value: 3 Guided learning hurs: 28 Unit summary A strke can be a life-threatening

More information

Acquired Optic Neuropathies

Acquired Optic Neuropathies Acquired Optic Neurpathies Jseph J. Pizzimenti, OD, FAAO Carl J. Pelin, OD, FAAO GOAL The gal f this presentatin is t prvide the participant with useful clinical infrmatin in the diagnsis and treatment

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

Eating Disorders. what do GPs need to know? John O Brien May 2016

Eating Disorders. what do GPs need to know? John O Brien May 2016 Eating Disrders what d GPs need t knw? Jhn O Brien May 2016 Overview Eating, weight and eating disrders Case scenari Hw t spt them When t refer Management pre and pst referral Eating and weight Adlescence

More information

Body chemistry and mood How our chemical makeup may affect our emotions. Circadian rhythm

Body chemistry and mood How our chemical makeup may affect our emotions. Circadian rhythm Presentatin: Bdy chemistry and md Bdy chemistry and md Hw ur chemical makeup may affect ur emtins Definitin Circadian rhythm A circadian rhythm is a rughly 24 hur cycle (Circa + Dia = the Circle f a Day)

More information

Patterns of Cholesterol Distribution in the Participants of a Screening Project

Patterns of Cholesterol Distribution in the Participants of a Screening Project Patterns f Chlesterl Distributin in the Participants f a Screening Prject Abdul Hamid Shaikh, S With guidelines similar t thse recmmended by the Natinal Chlesterl Educatin Prgram (NCEP), 3,3 individuals

More information

Memory Screening Site s PROGRAM HANDBOOK

Memory Screening Site s PROGRAM HANDBOOK Memry Screening Site s PROGRAM HANDBOOK 866-232-8484 www.alzfdn.rg/memry-screening/ Table f Cntents Page 3 Page 5 Page 6 Page 7 Page 8 Page 10 Page 12 Page 13 All Abut the Natinal Memry Screening Prgram

More information

Paediatric Sepsis Form. Sinéad Horgan SSWHG Sepsis Lead

Paediatric Sepsis Form. Sinéad Horgan SSWHG Sepsis Lead Paediatric Sepsis Frm Sinéad Hrgan SSWHG Sepsis Lead www.hse.ie/sepsis Definitin A life-threatening rgan dysfunctin due t a dysregulated hst respnse t infectin N cnfirmatry test Bld cultures are psitive

More information

ANNUAL PROGRESS REPORT

ANNUAL PROGRESS REPORT ANNUAL PROGRESS REPORT TO: Bard f Directrs ;m/ FROM: Jan O. Weiss, Executive Directr. DATE: Octber, 1993 QUARTERLY REPORT: Octber 1, 1992 thrugh September 30, 1993 Membership as f September 30, 1993 Individual

More information

Request for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax

Request for Prior Authorization for Click here to enter text. Website Form   Submit request via: Fax Request fr Prir Authrizatin fr Click here t enter text. Website Frm www.highmarkhealthptins.cm Submit request via: Fax - 1-855-476-4158 Updated: 05/2018 DMMA Apprved: 05/2018 All requests fr Intravenus

More information

2018 Medical Association Poster Symposium Guidelines

2018 Medical Association Poster Symposium Guidelines 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the

More information

CALVIN JOHNSON JR. FOUNDATION 2015 PANCREATIC CANCER RESEARCH SCHOLARSHIP

CALVIN JOHNSON JR. FOUNDATION 2015 PANCREATIC CANCER RESEARCH SCHOLARSHIP I. Intrductin CALVIN JOHNSON JR. FOUNDATION 2015 PANCREATIC CANCER RESEARCH SCHOLARSHIP The Calvin Jhnsn Jr. Fundatin, Inc. (CJJRF) is a nn-prfit 501(c)(3) rganizatin funded in 2008 by Calvin MEGATRON

More information

Tick fever is a cattle disease caused by any one of the following blood parasites:

Tick fever is a cattle disease caused by any one of the following blood parasites: Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus

More information

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION The Bitechnlgy Innvatin Organizatin (BIO) and ur member

More information

Iron and Iron Deficiency

Iron and Iron Deficiency Irn and Irn Deficiency Irn and why we need it Irn is a mineral needed by ur bdies. Irn is a part f all cells and des many things in ur bdies. Fr example, irn (as part f the prtein hemglbin) carries xygen

More information

What You Need to Know About ZIKA VIRUS

What You Need to Know About ZIKA VIRUS What Yu Need t Knw Abut ZIKA VIRUS Refugee and Immigrant Health Seminar Tuesday, Nvember 1, 2016 Malaya Fletcher, MPH Glbal Migratin & Mnitring Crdinatr PDPH Divisin f Disease Cntrl 1 Backgrund n Zika

More information

Epileptogenesis: A Clinician s Perspective

Epileptogenesis: A Clinician s Perspective Epileptogenesis: A Clinician s Perspective Samuel F Berkovic Epilepsy Research Centre, University of Melbourne Austin Health Epileptogenesis The process of development and sustaining the propensity to

More information

Epilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie

Epilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie Epilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie dr. Hannah Stamberger prof. dr. Peter De Jonghe Neurogenetics group, DMG, VIB http://www.molgen.vib-ua.be Disclosures

More information

BIOLOGY 101. CHAPTER 15: The Chromosomal Basis of Inheritance: Locating Genes Along Chromosomes

BIOLOGY 101. CHAPTER 15: The Chromosomal Basis of Inheritance: Locating Genes Along Chromosomes BIOLOGY 101 CHAPTER 15: The Chrmsmal Basis f Inheritance: Lcating Genes Alng Chrmsmes Lcating Genes Alng the Chrmsme CONCEPTS: 15.2 Sex-linked genes exhibit unique patterns f inheritance 15.3 Linked genes

More information

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα Γ. Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν.Α The nrmal pericardium is

More information

Pandemic H1N1 2009: DrillSafe Update. David Blizzard BD Manager, Energy Mining and Infrastructure

Pandemic H1N1 2009: DrillSafe Update. David Blizzard BD Manager, Energy Mining and Infrastructure Pandemic H1N1 2009: DrillSafe Update David Blizzard BD Manager, Energy Mining and Infrastructure Pandemic H1N1 Update CDC.Gv USA Pandemic H1N1 Summary Pints Virus cntinues t spread with nearly all WHO

More information

insights2017 QLD Kids Helpline Statistical Summary Queensland Insights into young people in Australia

insights2017 QLD Kids Helpline Statistical Summary Queensland Insights into young people in Australia insights2017 QLD Kids Helpline Statistical Summary Queensland Insights int yung peple in Australia Intrductin What is Kids Helpline? What this reprt is abut and wh is it fr Ntes n data cllectin, analysis

More information

Child s Name: Date of Birth: TAKE THIS SHEET TO EVERY DOCTOR S APPOINTMENT

Child s Name: Date of Birth: TAKE THIS SHEET TO EVERY DOCTOR S APPOINTMENT Date f Birth: TAKE THIS SHEET TO EVERY DOCTOR S APPOINTMENT Prtable Medical Summary Name: Date Updated: / / Address: Phne: Mbile: E-mail: DOB: SSN: - - Allergies: Pertinent Persnal Characteristics: What

More information

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland AWARD NUMBER: W81XWH-14-1-0444 TITLE: Culd HER2 Hetergeneity Open New Therapeutic Optins in Patients with HER2- Primary Breast Cancer? PRINCIPAL INVESTIGATOR: Gary Ulaner, MD, PhD CONTRACTING ORGANIZATION:

More information

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties

More information

The Four Links of Obesity: Diabetes, Fatty Liver, Cardiomyopathy and AF The Potential Benefit and Rapid Evolution of Bariatric Surgery

The Four Links of Obesity: Diabetes, Fatty Liver, Cardiomyopathy and AF The Potential Benefit and Rapid Evolution of Bariatric Surgery The Fur Links f Obesity: Diabetes, Fatty Liver, Cardimypathy and AF The Ptential Benefit and Rapid Evlutin f Bariatric Surgery Michael E. Farkuh, MD, MSc Peter Munk Chair in Multinatinal Clinical Trials

More information

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA)

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA) Plicy Medical Plicy Manual Apprved: D Nt Implement Until 1/1/18 Applied Behaviral Analysis (ABA) This medical plicy will apply t self-funded grups upn their renewal, beginning 1/1/18. Des nt apply t BlueCare.

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient Image Surce: https://s-media-cache-ak0.pinimg.cm/736x/7c/29/91/7c2991805f004e1ca05e42a79883f4a7.jpg 6/30/2017 Curse Objectives A Practical Guide t Cding fr Audilgists in 2017 Megan Keirans, AuD University

More information

Appendix C Guidelines for treating status epilepticus in adults and children

Appendix C Guidelines for treating status epilepticus in adults and children Appendix C Guidelines fr treating status epilepticus in adults and children 1.1 Treating cnvulsive status epilepticus in adults General measures 1st stage (0 10 minutes) Secure airway and resuscitate Administer

More information

Seizure Recognition & First Aid

Seizure Recognition & First Aid Seizure Recgnitin & First Aid 1 Objectives Recgnize cmmn seizure types and their pssible impact n individuals Knw apprpriate first aid Recgnize when a seizure is a medical emergency Prvide scial and academic

More information

Data Fusion for Predicting Breast Cancer Survival

Data Fusion for Predicting Breast Cancer Survival Data Fusin fr Predicting Breast Cancer Linbailu Jiang, Yufei Zhang, Siyi Peng Mentr: Irene Kaplw December 11, 2015 1 Intrductin 1.1 Backgrund Cancer is mre f a severe health issue than ever in ur current

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

Update on Concussions in Soccer

Update on Concussions in Soccer Update n Cncussins in Sccer Ricard E. Clberg, M.D., RMSK Andrews Sprts Medicine & Orthpedic Center American Sprts Medicine Institute Hw many here have had a cncussin? Definitins Signs & symptms Management

More information

Organizational Capacity for Change and Patient Safety

Organizational Capacity for Change and Patient Safety Organizatinal Capacity fr Change and Patient Safety Debrah M. Nadzam, PhD, FAAN - Jint Cmmissin Resurces Lrrie Jnes-Hartley, MSN, CRRN-A - Durham Reginal Hspital Presentatin Objectives Briefly describe

More information

PSYCHOSEXUAL ASSESSMENTS for Children and Adolescents with Problematic Sexual Behavior. Who is qualified to conduct a psychosexual evaluation?

PSYCHOSEXUAL ASSESSMENTS for Children and Adolescents with Problematic Sexual Behavior. Who is qualified to conduct a psychosexual evaluation? PSYCHOSEXUAL ASSESSMENTS fr Children and Adlescents with Prblematic Sexual Behavir When a child r adlescent is suspected r bserved t have engaged in what may be sexually inapprpriate r sexually aggressive

More information

Test Blueprinting II: Creating a Test Blueprint NBME

Test Blueprinting II: Creating a Test Blueprint NBME Test Blueprinting II: Creating a Test Blueprint NBME Natinal Bard f Medical Examiners 3750 Market Street Philadelphia, PA 19104 Test Blueprinting II: Creating a Test Blueprint Cpyright 2019 Natinal Bard

More information

Instructions regarding referral of patients to the Persistent Pain Service

Instructions regarding referral of patients to the Persistent Pain Service Prtsmuth Persistent Pain Service Lng Term Cnditins Suite Grund Flr, Blck A St Mary s Cmmunity Health Campus Miltn Rad Prtsmuth Hampshire PO3 6AD Tel: 23 9268 485 Fax: 23 9268 21 Dear GP Instructins regarding

More information

What Should One Know About Thalassaemia Minor

What Should One Know About Thalassaemia Minor What Shuld One Knw Abut Thalassaemia Minr What Is Thalassaemia? Thalassaemia is a cmmn inherited genetic disrder f hemglbin (Hb). T understand Thalassaemia ne shuld knw a bit mre abut Hb and its Structure

More information

Sasan Dabiri, MD, Assistant Professor

Sasan Dabiri, MD, Assistant Professor Sasan Dabiri, MD, Assistant Prfessr Department f Otrhinlarynglgy Head & Neck Surgery Amir Alam Hspital Tehran University f Medical Sciences March 2016 s - d a b i r i @ t u m s. a c. i r Backgrund Diagnsis

More information

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential

More information

Module 6: Goal Setting

Module 6: Goal Setting Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals

More information

Annual Principal Investigator Worksheet About Local Context

Annual Principal Investigator Worksheet About Local Context Cmpleting the NCI CIRB Annual Principal Investigatr Wrksheet Abut Lcal Cntext and the Study-Specific Wrksheet Abut Lcal Cntext at the University f Iwa All investigatrs cnducting research with the Natinal

More information

FIGHT DEMENTIA ACTION PLAN

FIGHT DEMENTIA ACTION PLAN FIGHT DEMENTIA ACTION PLAN DEMENTIA IS A HEALTH PRIORITY Dementia will be the majr health prblem f this century. Over ne millin Australians are already affected by the disease themselves r are caring fr

More information

The principles of evidence-based medicine

The principles of evidence-based medicine The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t

More information

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1 State Health Imprvement Plan 2017-2021 Chsing Pririties, Creating a Plan DHHS DPH - SHIP Pririties (Sept2016) 1 Creating a Plan: 2017-2021 SHIP Welcme! Wh s here? What is the State Health Imprvement Plan

More information